Biofil Chemicals Hits 52-Week Low as Stock Plummets to Rs. 40.01

Biofil Chemicals & Pharmaceuticals has reached a new 52-week low, hitting Rs. 40.01 on October 9, 2025. This marks a significant decline for the microcap company, which has seen its stock price drop by 46% over the past year, contrasting sharply with the Sensex's modest gain of 0.51% during the same period.
Despite today's performance, where Biofil outperformed its sector by 1.33%, the stock continues to trade below its moving averages across various time frames, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This trend indicates ongoing challenges in maintaining upward momentum.

The company's long-term fundamentals reflect a CAGR growth in operating profits of -25.47% over the last five years, coupled with a weak EBIT to interest ratio of 0.81, suggesting difficulties in servicing its debt. Additionally, the return on equity stands at a modest 4.38%, indicating low profitability relative to shareholders' funds.

While Biofil Chemicals has reported positive quarterly results, including a PAT of Rs. 2.41 crore and an EPS of Rs. 1.48, the overall performance remains below par, with the stock underperforming against broader market indices.